| Literature DB >> 31137612 |
P Yáñez-Sedeño1, A González-Cortés2, S Campuzano3, J M Pingarrón4.
Abstract
Proper functionalization of electrode surfaces and/or nanomaterials plays a crucial role in the preparation of electrochemical (bio)sensors and their resulting performance. In this context, copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC) has been demonstrated to be a powerful strategy due to the high yields achieved, absence of by-products and moderate conditions required both in aqueous medium and under physiological conditions. This particular chemistry offers great potential to functionalize a wide variety of electrode surfaces, nanomaterials, metallophthalocyanines (MPcs) and polymers, thus providing electrochemical platforms with improved electrocatalytic ability and allowing the stable, reproducible and functional integration of a wide range of nanomaterials and/or different biomolecules (enzymes, antibodies, nucleic acids and peptides). Considering the rapid progress in the field, and the potential of this technology, this review paper outlines the unique features imparted by this particular reaction in the development of electrochemical sensors through the discussion of representative examples of the methods mainly reported over the last five years. Special attention has been paid to electrochemical (bio)sensors prepared using nanomaterials and applied to the determination of relevant analytes at different molecular levels. Current challenges and future directions in this field are also briefly pointed out.Entities:
Keywords: azide-alkyne cycloaddition; copper(I) catalyzed click chemistry; electrochemical (bio)sensors; nanomaterials
Mesh:
Substances:
Year: 2019 PMID: 31137612 PMCID: PMC6566994 DOI: 10.3390/s19102379
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Electrochemical platforms prepared by Cu(I)-catalyzed azide–alkyne cycloaddition (click chemistry).
| Electrode Substrate | “Clicked” Materials | Click Strategy | Electrochemical Platform | Application/Analyte | Transduction Technique | Analytical Characteristics | Ref. |
|---|---|---|---|---|---|---|---|
| AuE | azide-undecanethiol SAM-4-pentynoic further covalent binding of Hb | ascorbate + CuSO4 | AuE/Hb | O2/H2O2 | amperometry | LR: 1.0–75 μmol L−1 | [ |
| BDDE | 5-Oxo-5-(prop-2-ynyloxy) pentanoic acid-BDDE and azido-propyl-mannose or lactose | ascorbate + CuSO4 | carbohydrate-BDDE | lectin | EIS | LR: up to 0.1 μmol L−1 | [ |
| AuE | 1-azidoundecan-11-thiol and propargyl-functionalized Fc | electroclick, CuSO4 30 min; −0.65 V vs. Ag/AgCl | propargyl-Fc/AuE | Cu2+/yoghurt | DPV | LR: 10−14–10−9 mol L−1 | [ |
| AuE | 1-azidoundecan-11-thiol-AuE and propargyl acrylate. MIP preparation by polymerization with MAAM and AIBN. HQ as the template | ascorbate + CuSO4 | MIP-AuE | HQ | amperometry | LR: up to 15 μmol L−1 | [ |
| AuE | 1-azidoundecan-11-thiol-AuE and propargyl-ferrocene | AA + CuSO4, 10 h | propargyl-Fc-AuE | AA | EIS | LR: 5–103
| [ |
| AuE | 4-ethylnylphenyl (4-EP) diazonium and azido-HRP | ascorbate + CuSO4 | HRP/AuE | H2O2 | amperometry | 5–930 μmol L−1 | [ |
| GCE | 4-azidobenzenediazonium and ethynylpyridine | ascorbate + CuSO4 | FePc/GCE | hydrazine | amperometry | LR: 10–340 μmol L−1 | [ |
| GCE | alkynyl-cobalt phthalocyanine (TA-Co Pc) and polymerized 4-azido-polyaniline (PANI-N3) | CuBr, 3h | TA-CoPc-N3-PANI/GCE | eserine | SWV | LR: 0.156–2.45 μmol L−1 | [ |
| PtE | azido-thiophene and ethynylferrocene | CuBr, DMF, PMDETA, 48 h | PtE | H2PO4− | CV | [ | |
| GCE | 4-azido-aniline diazonium-GCE and 10-undecyn-1-thiol-AuNPs | ascorbate + CuSO4 | AuNPs-GCE | NO2− oxidation | CV/amperometry | [ | |
| ITO | polymerized azido-EDOT with PSS and ethynyl-ferrocene | ascorbate + CuSO4 | PSS-PEDOT-ITO | DA | LSV | LR: 0.01–0.9 mmol L−1 | [ |
| GCE | 4-azidoaniline and 4-ethynylpyridine | electroclick, CuSO4 | FeTCPc/GCE | hydrazine | amperometry | LR: 0.2–1 mmol L−1 | [ |
| GCE | azide-AuNPs and alkyne-2-cyano-prop-2-yl-dithio-benzoate. MIP preparation by polymeri-zation with EGDMA, AIBN and PEG. Fenitrothion as template | ascorbate + CuSO4 | MIP-GCE | fenitrothion/cabbage, apple peel | DPV | LR: 0.01–5 μmol L−1 | [ |
| GCE | azide-MWNTs (N3-MWNTs) and 1-propargyl-3-butylimidazolium bromide (IL). MIP prepara-tion by polymerization with 4-vinylpyridine, EGDMA and AIBN. Tartrazine as template | ascorbate + CuSO4 | MIP-MWCNTs-IL@PtNPs/GCE | tartrazine | DPV | LR: 0.03–5.0 and | [ |
| BDDE | 4-azido-aniline-BDDE and ethynyl-ferrocene or alkyne-modified ss-DNA | AA + CuSO4 (Fc); TBTA + CuBr (DNA), 12 h | Fc-BDDE or | electrode modification | [ | ||
| GCE | 4-azidobenzenediazonium and Fe(II) tetrakis (5-hexyn-oxy) phtalocyanine (FcPc) | Cu(PPh3)3Br; TEA | FePc-GCE | hydrazine | CV/amperometry | LR: 0.1–1.0 mmol L−1 | [ |
| GCE | 4-azido-aniline diazonium-GCE and 10-undecyn-1-thiol-AuNPs | electroclick, CuSO4, 1 h | AuNPs-GCE | electrode modification | [ | ||
| SPCE | azide-PEG4-AuNP-PAMAM and acetylene-PEG4-SPCE | ascorbate, Cu(II), | azide-PEG4-NHS | Cu2+/water | DPSV after AuNPs dissolution | LR: 50–107
| [ |
| GCE | azide CdSe/ZnS QDs and Fe(II) tetra-kis (5-hexyn-oxy) phtalocyanine (FcPc) | ascorbate; CuSO4 | FePc-QDs-GCE | paraquat | DPV | LOD: 5.9 nmol L−1 | [ |
| GCE | 4-azidobenzenediazonium and Mn(II) tetrahexynyl-phtalocyanine | Cu(PPh3)3Br; TEA | MnPc-GCE | hydrazine | amperometry | LR: 0.2–1.0 mmol L−1 | [ |
| AuE | azide-Cu-calix[6]azacryptand and alkyne-terminated thiol SAM | electroclick, Cu(6-Br TMPA) −0.30 V vs. SCE | Cu-calix[6] azacryptand-AuE | alkylamines | CV | [ | |
| AuE | 4-azidobenzenediazonium and Co(II)-or Mn(II)-tetra-(4-propargyloxy) phen-oxy phthalocyanines (MTPrOPhOPcs) | CuI, DMF/ACN | MTPrOPhOPcs/AuE | H2O2 | amperometry | LR: 10–80 μmol L−1 | [ |
| GCE | 4-azidobenzenediazonium and Co(II) tetrakis 4-((4-ethynylbenzyl) oxy) phthalocyanine | Cu(PPh3)3Br; TMA | CoPc-GCE | hydrazine | amperometry | LR: 0.1–1.0 mmol L−1 | [ |
| ITO | alkynyl-manganese phtalocyanine (TA-MnPc) and 4-azido polyaniline (PANI-N3) | electroclick, CuSO4, | TA-MnPc-N3-PANI/ITO | fenitrothion | SWV | LR: 0.05–2.81 μmol L−1 | [ |
| GCE | tetrakis (5-hexyn-oxy) phthalocyanine (CoPc) and azido-aniline | Cu(PPh3)3Br | CoPc/GCE | Hg(II), Pb(II), Cu(II), Cd(II) | DPASV | LR: up to 0.1 mmol L−1 | [ |
| GCE | azide-SWCNTs and BODIPY | ascorbate + CuSO4 | BODIPY-SWCNTs/GCE | guanine (G) adenine (A) | DPV | LOD: 1.07 μmol L−1 (G); | [ |
| GCE | azide-SWCNTs and BODIPY | ascorbate + CuSO4 | BODIPY-SWCNTs/GCE | eserine/orange juices | SWV | LR: 0.25–2.25 μmol L−1 | [ |
| GCE | azide CdSe/ZnS QDs and Fe(II), Co(II) or Mn(II) tetrakis 4-((4-ethyl-benzyl) oxy) phtalocyanine (MPc) | Cu(PPh3)3Br; TMA | MPc-QDs-GCE | H2O2 | amperometry | LR: 0.1–1.0 mmol L−1 | [ |
AA: ascorbic acid; AIBN: azobisisobutyronitrile; BODIPY, 4,4-difluoro-8-(4-hydroxyphenyl)-2,6-diethynly-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene; (CuPPh3)3Br: bromotris (triphenylphosphine) copper(I): DA: dopamine; DBCO-NH2: dibenzocyclooctyne-amine; DTPA: dithiol phosphoramidite; EGDMA: ethylene glycol dimethacrylate; 6-eTMPA: 6-ethynyl-tris(2-pyridylmethyl) amine; FeTCPc: Fe(II)tetracarboxyphtalocyanine; HAS: human serum albumin; MAAM: N,N-methylene-bis (acrylamide); PAMAM, poly(amidoamine); EDOT: polyethylenedioxythiophene; PMDETA: N,N,N′, N″,N″-pentamethyldiethylenetriamine; PSS: poly(styrene-4-sulfonate); SPCE: screen-printed carbon electrode; TBTA: tris (benzyltri-azolyl-methyl) amine; TEA, triethylamine; TMPA: tris (2-pyridylmethyl) amine).
Figure 1Functionalization of a GCE with azide groups by electrografting (top) and attachment of Fe(II) phtalocyanine on electrografted GCE via click chemistry (A); multistep functionalization of a BDDE by electrografting and attachment of ethynylferrocene via click chemistry (B). Reprinted from [28] (A) and [27] (B) with permission.
Figure 2Strategy for electroclick grafting of [Cu(H2O)]2+ on gold electrodes modified with alkyne-terminated alkane thiols (A); Hb-functionalization of Au surface via click chemistry on mixed SAMs (B); fundamentals of copper(II) detection involving CuAAC electroclick (C). Reprinted from [33] (A), [14] (B) and [16] (C) with permission.
Figure 3Preparation of CYT-1 (a) and CYT-1-SWCNTs (b) (A). Schematic diagram of modification of azido MWCNTs with IL and the preparation of MWCNTs–IL@PtNPs composite (B). Method for the preparation of 3D SWCNTs–BODIPY from azido-SWCNTs and double terminal ethynyl BODIPY (C). Reprinted from [47] (A), [26] (B), and [39] (C) with permission.
Figure 4Clicking of (OAc)Mn tetrakis(5-hexyn-oxy) phtalocyanine to a grafted GCE (OAc: acetate) (A). Scheme of electrochemical grafting and click reaction of MTPrOPhOPcs onto grafted AuE (B). Reprinted from [32] (A) and [34] (B).
Figure 5Schematic illustration of the anodic stripping voltammetric detection of Cu2+ ions by coupling with a Cu(I)-catalyzed azide alkyne click reaction and AuNP-PAMAM signal amplification. Reproduced from [30] with permission.
Electrochemical biosensors prepared by Cu(I)-catalyzed azide–alkyne cycloaddition.
| Electrode Substrate | Clicked Materials | Click Strategy | Electrochemical Biosensor | Application/Analyte | Transduction Technique | Analytical Characteristics | Ref. |
|---|---|---|---|---|---|---|---|
| AuE | 1,4-dialkynylbenzene and azido-HRP | sodium ascorbate, CuSO4, 24 h | HRP-AuE | H2O2 | amperometry | LR: 5–700 μmol L−1 | [ |
| SPCE | grafted 4-((trimethysilyl) ethynyl) diazonium and azido-HRP | electroclick, CuSO4, | HRP-SPCE | H2O2 | amperometry | LR: 5–50 mmol L−1 | [ |
| GCE | alkyne-IgG and azide-SWCNTs | AA, CuSO4, overnight | HRP-anti-IgG-IgG-SWCNT/GCE | IgG | amperometry | LOD: 30 | [ |
| Au-PWE | 1-azidoundecan-11-thiol and alkyne-Ab1; azide-Fe3O4@SiO2 (MSN) and propargyl Ab2 and HRP | AA, CuSO4, 18 h | Ab2/HRP-MSN | micro-cystin-LR | DPV | LR: 0.01–200 μg mL−1 | [ |
| SPCE | azido-aptamer and ethynyl-modified SPCE | electroclick; CuSO4 | H-Eth-Ar-p-NO2-Ar-SPCE | OTA/beer | EIS | LR: 1.25–500 ng L−1 | [ |
| GCE | azido-aniline and alkyne-hIgG | electroclick; Cu (II) | HRP-anti-gIgG/anti-hIgG-hIgG-GCE | hIgG | amperometry | LR: 0.1–10 ng mL−1 | [ |
| AuE | bis(DTPA)-hexynyl and azide-PEG3-Biotin | electroclick, TBTA + CuSO4, −0.3 V vs. Pt, 3 h | Strep-Biotin-AuE | Biotin-HSA | EIS | LR: 10–104
| [ |
| SPCE | propargylamine-GO and azide-MSN; 4-pentinoic acid-Ab2 and azide-MSN | AA, CuSO4, 24 h | GO-MSN-Ab2-CA253-Ab1-GO/SPCE | CA 153 | DPV | LR: 10−3–200 U mL−1 | [ |
| AuNPs/SPCE | azido-UDT and alkynyl-LBA | AA, CuSO4 DMSO/Tris buffer, 30 min | [Ru(NH3)6]3+/Lys-LBA-UDT-AuNPs/SPCE | lysozime | SWV | LR: 1.0–50.0 | [ |
| AuE | azido-PEDOT and acetylene-DNA | CuI, TBTA, DIPEA/DMSO; 20–24 h | sDNA-PEDOT/AuE | HCV | DPV | LR: 1–20 nmol L−1 | [ |
| GCE | azide-Jug and alkynyl-APAP-hapten | ascorbate, CuSO4H2O/t-butanol, 36 h | anti-APAP-APAP/poly (Jug-co-Jug-APAP)-GCE | APAP | SWV | DR: 1–50 nmol L−1 | [ |
| AuE | MB-hairpin 5′alkyne-ssDNA and 3′azide ssDNA | ascorbate + Cu (II) | Oligo-A/Oligo-B/hairpin/AuE | Cu2+ | SWV | LR: 5.0–1000 nmol L−1 | [ |
| AuE | ssDNA hybridized with thiol-and azido-hairpin and ethynylferrocene | AA, CuSO4 | hairpins/MCH/ssDNA-ethynylferrocene | ssDNA | DPV | LR: 1–1000 nmol L−1 | [ |
| SPCE | alkynyl anthraquinone (AQ) and azido galactoside (Gal) | ascorbate; CuSO4 | GalAQ/Gr/SPCE | PNA, | EIS | LR: 100–900 nmol L−1 (PNA); | [ |
| Au-PWE | propargyl-folic acid (FA) and: | AA, CuSO4 | Au@PtPdNPs-FA-cell-FA-Au-PWE | K562 cells | DPV | DR: 100–107 cells mL−1 | [ |
| PtCE | hydroxypropyl cellulose (HPC) and azide-Fc | CuBr, PMDETA, | HRP/HPC-Fc-PtCE | H2O2 | amperometry | LR: 0.1–8 μmol L−1 | [ |
| GCE | alkyne-IgG and azide-MWCNTs | AA, CuSO4, overnight | poly-HRP-Strept-Biotin-antiTGF-TGFβ-anti-TGF-IgG-MWCNT/SPCE | TGF-β1 | amperometry | LR: 5–200 | [ |
| GCE | 4-azido aniline and 4-pentynoyl -peptide | ascorbate, CuSO4 18 h | Strept-Biotin-peptide/Jug-Ph-NH2-GCE | PSA | SWV | DR: 10−12–10−6 mol L−1 | [ |
| BDDE | TIPs-Eth-Ar and azide peptide[(Ala-Arg-Leu-Pro-Arg)2Lys-Lys(N3)] and alkyne-terminated-BDD | ascorbate, CuSO4 | IFV-peptide-BDDE | H1N1, | EIS | DR: 400–8000 pfu mL−1 | [ |
| AuE | ssDNA hybridized with thiol- and azido-hairpin and ethynylferrocene | electroclick; CuSO4 | hairpins/MCH/ssDNA-ethynylferrocene | ssDNA | DPV | LR: 1–1000 | [ |
| AuE | alkyne-Fc-modified aptamer and azide UDT/UDT SAM | electroclick, Cu(II) | Fc-aptamer-UDT/N3-UDT/AuE | VEGF165 | amperometry | LR: up to 0.5 μmolL−1 | [ |
| AuE | azido-DNA and alkynyl-DNA/HRP-AuNPs | ascorbate; Cu(II) | HRP/AuNPs-DNA-alkyne-azido-DNA/AuE | Cu2+/water | DPV, H2O2 addition | LR: 1.0 amol L−1–10 mmol L−1 | [ |
| AuE | BPEI-Fc/CB[7]-N3-GO and 5′alkyne-Apt(S1) | electroclick; Cu(II) CV (0.5 to −0.3 V) 10 min, 12 h incubation | BPEI-Fc-CB[7]-N3-GO/S1/MCH/S2/AuE | VEGF165 | SWV | DR:10 fg mL−1–1ng mL−1 | [ |
| AuE | azido-labeled aptamer and ethynyl -ferrocene | electroclick; CuSO4 | ethynylferrocene-N3 | thrombin/serum | DPV | LR: 0.1–1000 nmol L−1 | [ |
| GCE | azide-dsDNA and PA | AA, released Cu(II), | Cu-PDA-Ab2-CA242-PA/Ab1-PEI-GO/GCE | CA 242 | SWV | LR: 10−4–100 U mL−1 | [ |
| AuSPE | azide-terminated aptamers and propargylacetic acid | ascorbate, CuSO4 THPTA; 7 h | PEI/rGO/AuSPE | BNP | DPV | LR:1–106 (BNP); 1–103
| [ |
| GCE | alkyne-IgG and azide-MWCNTs | AA, CuSO4, overnight | poly-HRP-Strept-Biotin-anti CXCL7-CXCL7-anti-CXCL7-IgG-MWCNT/SPCE | CXCL7/serum | amperometry | LR: 0.5–600 | [ |
APAP: acetaminophen; BPEI: branched: poly(ethyleneimine); CA 242: carbohydrate antigen 24-2; CB[7]: cucurbit[7]uril; DR: dynamic range; Fc: ferrocene; HCV: hepatitis C virus; IFV: influenza virus; Jug-Ph-NH2 Redox transducer 2-[(4-aminophenyl)sulfanyl]-8-hydro-xy-1,4-naphthoquinone; LBA: antilysozyme binding aptamer; LR: linear range; Lys: lysozyme; MCH: 6-mercapto-1-hexanol; MSN: magnetic silica nanoparticles; OTA: ochratoxine A; PA: propiolic acid; PEI: poly(ethyleneimine); PNA: peanut agglutinin; PtCE: platinized carbon electrodes; PWE: paper working electrode; TBTA: tris(benzyltriazolylmethyl)amine; THPTA: tris(3-hydroxypropyl triazolylmethyl) amine; THI, thionine; UDT, undecan-1-thiol.
Figure 6Preparation of a HRP-DEB biosensor (A). Functionalization of gold surface with bis(DTPA)-hexynyl and mercaptopropanol; biotin grafting by click reaction followed by streptavidin binding (B). Reproduced from [53] (A) and [59] (B) with permission.
Figure 7Schematic illustration of electrochemical DNA biosensors prepared onto gold electrodes by direct immobilization of dually thiol- and azide-labeled probes, followed by hybridization and electroclick reaction (inset) with ethynilferrocene (A). Fabrication of a mixed monolayer of 11-azido-1-undecanethiol (N3UDT) and UDT, followed by electroclick (inset) with Fc and the alkyne-modified probe, and target binding (B). Reprinted from [65] (A) and [73] (B) with permission.
Figure 8Preparation of BPEI-Fc-CB[7]-N3-GO composite (A) and schematic illustration of the electroclick biosensing platform constructed for the determination of VEGF165 (B). Reprinted from [75].
Figure 9Steps involved in the construction of an electrochemical aptasensor for BNP and cTnI cardiac biomarkers. Preparation of gold SPE-rGO/polyethyleneimine (PEI) by electrophoretic deposition (EPD) of rGO/PEI onto gold screen-printed electrodes (I) and covalent binding of propargylacetic acid and PEI (II) (A). Integration of N3-functionalized aptamers by click chemistry (III), and blocking with pyrene-polyethylene glycol (PEG) (green layer) (B). Reproduced from [78] with permission.
Figure 10Schematic illustrations of the sensing strategies reported for copper ion detection by target-induced click conjugation of two oligonucleotides labeled with azides and alkynes using methylene blue-functionalized hairpin DNA as the template (A) or HRP as indicator and AuNPs as enhancer (B). Inset: preparation of alkynyl-DNA/HRP/BSA/AuNPs. Reprinted from [64] (A) and [74] (B) with permission.
Figure 11Schematic display of the portable chemical sensor for the determination of histidine, making use of click chemistry and PGM. Reproduced from [81] with permission.
Figure 12Schematic illustrations of the steps involved in the preparation of electrochemical immunosensors for CA 153 (A) and CXCL7 (B). See text for details. Reprinted from [60] (A) and [79] (B) with permission.
Figure 13Synthesis of Gal-AQ (A) and scheme of the label-free impedance detection of receptor-rich live cancer cells (B). Reproduced from [66] with permission.